The aim is to identify the genetic causes, understand the pathology, prevent the transmission and, finally,
develop new therapeutic approaches for these devastating often fatal disorders.
These results, published in the journal Nature, could be used to
develop new therapeutic approaches.
«Against the background of these findings, we can, for example identify possible risk groups and
develop new therapeutic approaches,» adds Dr. Christian Gieger (HMGU).
«The current study reveals the new roles of innate immunity in ALS pathomechanism and provides a clue to
develop a new therapeutic approach for protecting ALS motor neurons.»
Liaison between clinical and basic sciences can be utilized to achieve this, including maximizing the potential of genomic data to tailor individualized treatments, collecting natural history information to identify disorder - specific management requirements,
developing new therapeutic approaches through improved knowledge of molecular pathways and protein network interactions, and testing potential new drugs via well - conducted clinical trials.
Not exact matches
The nanoparticles
developed by Dr. Rana and colleagues offer a potential
new strategy for delivering this powerful
therapeutic approach.
Scientists in Germany have
developed a
new approach that may prevent leukemia and lymphoma patients from
developing graft - versus - host disease (GvHD) after
therapeutic bone marrow transplants.
«This mechanism may offer the potential to
develop an entirely
new therapeutic approach,» says C. Ronald Kahn, M.D., Joslin's chief academic officer, Mary K. Iacocca Professor of Medicine at Harvard Medical School and senior author of a paper on the research published in the journal Nature.
The Helmholtz Zentrum München aims to make basic research findings available quickly for clinical application as well as to
develop new approaches to diagnostic and
therapeutic procedures and prevention.
Interestingly, genomic analyses suggested that ESCC and head and neck squamous cell carcinoma (HNSCC) shared some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking.These findings would provide a brand -
new insight into the understandings of ESCC tumorigenesis, and would help clinicians to
develop more effective diagnostic and
therapeutic approaches for ESCC.
These findings would provide a brand -
new insight into the understandings of ESCC tumorigenesis, and would help clinicians to
develop more effective diagnostic and
therapeutic approaches for ESCC.
new technological advances in the field of live imaging [e.g. magnetic resonance imaging (MRI) and optical in - vivo imaging] to
develop new preventive and / or
therapeutic approaches for these diseases.
«This partnership puts our mRNA Therapeutics platform in the hands of Karolinska's world - class scientists and clinical researchers to
develop new drugs and
therapeutic approaches that can not be done with small molecules or biologics — bringing
new hope to patients with serious diseases.»
Our goal is to propose and
develop new therapeutic strategies, including personalized
approaches to each individual's disease.
``... in order to better understand the pathogenesis of AD [Alzheimer's Disease], to study and to monitor the activity and the efficacy of
new therapeutic approaches such as KD [Ketogenic Diet] and, finally, to
develop a personalized management of the disease».
This
new partnership aims to tackle the problem by establishing a list of key objectives which include researching and
developing a
new approach to mental wellbeing and health in education, integrating educational and
therapeutic practice in supporting the most vulnerable students and
developing a
new way of dealing with mental health by drawing on latest mental health knowledge and advice.
He's enjoyed a long time apprenticeship in narrative ideas and
therapeutic practices and is presently
developing a
new «relational interviewing»
approach to working with conflicted couple relationships.